1. Home
  2. LOPE vs GH Comparison

LOPE vs GH Comparison

Compare LOPE & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LOPE

Grand Canyon Education Inc.

HOLD

Current Price

$171.23

Market Cap

4.6B

Sector

Real Estate

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$112.15

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOPE
GH
Founded
1949
2011
Country
United States
United States
Employees
N/A
2021
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
13.2B
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
LOPE
GH
Price
$171.23
$112.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
21
Target Price
$220.00
$99.48
AVG Volume (30 Days)
363.9K
1.8M
Earning Date
02-18-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.46
N/A
Revenue
$1,090,524,000.00
$902,569,000.00
Revenue This Year
$9.20
$35.00
Revenue Next Year
$6.83
$26.80
P/E Ratio
$23.00
N/A
Revenue Growth
7.05
30.38
52 Week Low
$149.83
$33.75
52 Week High
$223.04
$112.43

Technical Indicators

Market Signals
Indicator
LOPE
GH
Relative Strength Index (RSI) 60.04 70.14
Support Level $163.45 $97.31
Resistance Level $174.22 $104.75
Average True Range (ATR) 3.72 3.83
MACD 1.37 0.26
Stochastic Oscillator 80.35 99.25

Price Performance

Historical Comparison
LOPE
GH

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges both online, on the ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: